Join Andelyn’s Newsletter

Your Source for Quality Insights on Cell and Gene Therapies

We are committed to advancing the future of cell and gene therapies. By subscribing to our newsletter, you’ll receive:

icon for expert perspectives
Expert perspectives on the latest industry developments
icon for educational content
Educational content on therapies from concept to commercialization
icon for exclusive insights
Exclusive insights into our pioneering work in rare diseases
icon for industry conferences
Updates on conference attendance and technical presentations

News & Press Releases

News

April 22, 2026

Andelyn Biosciences, ENCell Enter Strategic Gene Therapy Manufacturing Pact Andelyn Biosciences, ENCell Enter Strategic Gene Therapy Manufacturing Pact
News

April 22, 2026

Andelyn, ENCell team on global gene therapy manufacturingAndelyn, ENCell team on global gene therapy manufacturing
Press Release

April 21, 2026

Andelyn Biosciences and ENCell Co., Ltd Announce Strategic Partnership to Expand Global Reach of Gene Therapy ManufacturingAndelyn Biosciences and ENCell Co., Ltd Announce Strategic Partnership to Expand Global Reach of Gene Therapy Manufacturing
Press Release

April 14, 2026

Andelyn Biosciences Partners with Evolyra Therapeutics for the Clinical Manufacturing of Gene Therapies for the Treatment of Limb-Girdle Muscular Dystrophies Andelyn Biosciences Partners with Evolyra Therapeutics for the Clinical Manufacturing of Gene Therapies for the Treatment of Limb-Girdle Muscular Dystrophies
View All News & Press Releases
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
PreferencesDenyAccept